Actively Recruiting
Study of Acupuncture Combined with PD-1PD-L1 Inhibitors and Chemotherapy for Advanced Lung Cancer Evaluating Effects on Treatment Response and Safety
Led by Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Updated on 2025-07-24
240
Participants Needed
3
Research Sites
26 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the effectiveness and safety of acupuncture combined with immunotherapy in people with advanced lung cancer. The study aims to find out if acupuncture can improve how well immunotherapy works and whether it makes the treatment safer. Participants have advanced forms of lung cancer and are treated with a standard Western medical regimen including PD-1PD-L1 inhibitors combined with chemotherapy.
CONDITIONS
Brief Title
Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer
Research Team
J
Jiarong FAN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
